About Molecular Detection
Molecular Detection Inc. (MDI), a US-based company with offices in Wayne, PA, Tunbridge Wells, UK and Jerusalem, Israel, is developing and commercializing a portfolio of sample-to-answer Detect-Ready® molecular diagnostic tests for the detection of infectious diseases. The company's first product, a ready-to-use, rapid detection panel for hospital-based MRSA screening, is currently commercially available in the EU and Australia. MRSA infections represent a growing problem to the healthcare system, and successful MRSA control efforts include the screening of individuals who may be potential carriers to prevent the spread of the disease. The Detect-Ready MRSA Panel provides increased accuracy, faster time to results and more efficient utilization of hospital resources compared to other MRSA diagnostic products. MDI's real-time PCR tests are based on novel, patented technologies for differential diagnosis and room-temperature stabilization. For more information, visit www.detect-ready.com.Contacts: Molecular Detection Inc.:
Media: Todd Wallach
Barbara Lindheim Chief Executive Officer
BLL Partners (215) 896-7001
|SOURCE Molecular Detection Inc.|
Copyright©2012 PR Newswire.
All rights reserved